SMFG vs TSHA
SMFG (SMFG) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
SMFG (SMFG) common stock.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
SMFG does not have a complete income-statement cache yet.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
SMFG currently screens at market cap $0. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the SMFG and TSHA stock pages for the full models.
Not investment advice.